This report discusses US over-the-counter (OTC) pharmaceuticals (at the manufacturers' level) for the years 2000 and 2005, with forecasts to 2010. Topics covered include market size, distribution and commercial status, product segmentation, regulatory considerations, market environment, distribution and commercial status forecasts, product forecasts, industry composition and leading participants. Distribution status segments include ethical products and OTC products; and commercial status segments include proprietary and generic products. Product segments cover nutritional, central nervous system, respiratory, gastrointestinal, dermatological, and anti-infective. This 17 page report also includes a highlights summary and resources section.

Companies Profiled

Johnson & Johnson
Pfizer Incorporated
Novartis International AG

For more information, please visit:
http://www.bharatbook.com/detail.asp?id=8751

####